Lista de obras -

A phase 1 study to evaluate the safety and immunogenicity of a recombinant HIV type 1 subtype C adeno-associated virus vaccine

artículo científico publicado en 2008

Alterations of the NK cell pool in HIV/HCV co-infection

artículo científico publicado en 2017

Bacteremia caused by a novel helicobacter species in a 28-year-old man with X-linked agammaglobulinemia.

artículo científico publicado en 2010

Cardiac Magnetic Resonance Reveals Signs of Subclinical Myocardial Inflammation in Asymptomatic HIV-Infected Patients

artículo científico publicado en 2016

Circulating levels of PRO-C3 reflect liver fibrosis and liver function in HIV positive patients receiving modern cART

artículo científico publicado en 2019

Circulating miRNA-122 levels are associated with hepatic necroinflammation and portal hypertension in HIV/HCV coinfection

artículo científico publicado en 2015

Circulating microRNAs as a marker for liver injury in human immunodeficiency virus patients

artículo científico publicado en 2014

Combination of tenofovir and lamivudine versus tenofovir after lamivudine failure for therapy of hepatitis B in HIV-coinfection

artículo científico publicado en 2006

Compartment-specific distribution of human intestinal innate lymphoid cells is altered in HIV patients under effective therapy

artículo científico publicado en 2017

Evidence for extensive genotypic diversity and recombination of GB virus C (GBV-C) in Germany ⬇️

artículo científico publicado el 1 de abril de 2011

Exposure to previous cART is associated with significant liver fibrosis and cirrhosis in human immunodeficiency virus-infected patients

artículo científico publicado en 2018

Fibroblast growth factor 21 is independently associated with severe hepatic steatosis in non-obese HIV-infected patients

scientific article published on 05 April 2019

GB virus C (GBV-C) infection in hepatitis C virus (HCV)/HIV-coinfected patients receiving HCV treatment: importance of the GBV-C genotype.

artículo científico publicado en 2006

GB virus C coinfection in advanced HIV type-1 disease is associated with low CCR5 and CXCR4 surface expression on CD4(+) T-cells

artículo científico publicado en 2010

Genetic polymorphisms associated with fatty liver disease and fibrosis in HIV positive patients receiving combined antiretroviral therapy (cART).

artículo científico publicado en 2017

HIV mono-infection is associated with an impaired anti-hepatitis C virus activity of natural killer cells

artículo científico publicado en 2015

HIV protease inhibitors in combination with boceprevir: are drug-drug interactions the same for all patients?

artículo científico publicado en 2012

HPV-associated anal lesions in HIV+ patients: long-term results regarding quality of life

scientific article published on 26 March 2020

Hepatitis C reinfection with protease inhibitor-resistant hepatitis C virus in an HIV-coinfected MSM

scientific article published on 31 October 2019

Hepatitis E Virus Seroprevalence Rate in HIV-Infected Patients in Germany: A Comparison of Two Commercial Assays

artículo científico publicado en 2015

Hyper-IgD and periodic fever syndrome (HIDS) due to compound heterozygosity for G336S and V377I in a 44-year-old patient with a 27-year history of fever

artículo científico publicado en 2016

Impact of low-level viremia on clinical and virological outcomes in treated HIV-1-infected patients

artículo científico publicado en 2015

In vitro activity of mecillinam and nitroxoline against Neisseria gonorrhoeae - re-purposing old antibiotics in the multi-drug resistance era

scientific article published on 04 June 2019

Injection Drug Use and Hepatitis C as Risk Factors for Mortality in HIV-Infected Individuals: The Antiretroviral Therapy Cohort Collaboration

artículo científico publicado en 2015

Limited Weight Impact After Switching From Boosted Protease Inhibitors to Dolutegravir in Persons With Human Immunodeficiency Virus With High Cardiovascular Risk: A Post Hoc Analysis of the 96-Week NEAT-022 Randomized Trial

artículo científico publicado en 2022

Liver Fibrosis in HIV Patients Receiving a Modern cART: Which Factors Play a Role?

artículo científico publicado en 2015

Liver fibrosis progression after acute hepatitis C virus infection in HIV-positive individuals

artículo científico publicado en 2011

Moderate endurance training (marathon-training) - effects on immunologic and metabolic parameters in HIV-infected patients: the 42 KM cologne project.

artículo científico

Nevirapine pharmacokinetics in HIV-infected and HIV/HCV-coinfected individuals

artículo científico publicado en 2009

Obstacles to hbv functional cure: Late presentation in HIV and its impact on HBV seroconversion in HIV/HBV coinfection

scientific article published on 03 October 2020

Return-to-health effect of modern combined antiretroviral therapy potentially predisposes HIV patients to hepatic steatosis.

artículo científico publicado en 2018

Risk of selecting K65R in antiretroviral-naive HIV-infected individuals with chronic hepatitis B treated with adefovir

artículo científico publicado en 2005

Role of GB virus C in modulating HIV disease

artículo científico

Survival and HLA-B*57 in HIV/HCV Co-Infected Patients on Highly Active Antiretroviral Therapy (HAART).

artículo científico publicado en 2015

Switching from boosted PIs to dolutegravir decreases soluble CD14 and adiponectin in high cardiovascular risk people living with HIV

artículo científico publicado en 2021

Switching tenofovir disoproxil fumarate to tenofovir alafenamide in a real life setting: what are the implications?

artículo científico publicado en 2020

The German National Registry of Primary Immunodeficiencies (2012-2017)

artículo científico publicado en 2019

The treatment of patients with HIV

artículo científico publicado en 2010

Treatment modification after starting cART in people living with HIV: retrospective analysis of the German ClinSurv HIV Cohort 2005-2017

artículo científico publicado en 2020

[Treatment of HIV in Pregnancy - Progress Over One Decade]

scientific article published on 04 December 2018

[Treatment of HPV-associated Anal Lesions in HIV-positive Patients - Comparison of Surgical Treatment and Topical Therapy with Imiquimod]

artículo científico publicado en 2018

microRNA-200a: A stage-dependent biomarker and predictor of steatosis and liver cell injury in human immunodeficiency virus patients.

artículo científico publicado en 2017

Lista de obras de

A phase 1 study to evaluate the safety and immunogenicity of a recombinant HIV type 1 subtype C adeno-associated virus vaccine

Alterations of the NK cell pool in HIV/HCV co-infection

Bacteremia caused by a novel helicobacter species in a 28-year-old man with X-linked agammaglobulinemia.

Cardiac Magnetic Resonance Reveals Signs of Subclinical Myocardial Inflammation in Asymptomatic HIV-Infected Patients

Circulating levels of PRO-C3 reflect liver fibrosis and liver function in HIV positive patients receiving modern cART

Circulating miRNA-122 levels are associated with hepatic necroinflammation and portal hypertension in HIV/HCV coinfection

Circulating microRNAs as a marker for liver injury in human immunodeficiency virus patients

Combination of tenofovir and lamivudine versus tenofovir after lamivudine failure for therapy of hepatitis B in HIV-coinfection

Compartment-specific distribution of human intestinal innate lymphoid cells is altered in HIV patients under effective therapy

Evidence for extensive genotypic diversity and recombination of GB virus C (GBV-C) in Germany ⬇️

Exposure to previous cART is associated with significant liver fibrosis and cirrhosis in human immunodeficiency virus-infected patients

Fibroblast growth factor 21 is independently associated with severe hepatic steatosis in non-obese HIV-infected patients

GB virus C (GBV-C) infection in hepatitis C virus (HCV)/HIV-coinfected patients receiving HCV treatment: importance of the GBV-C genotype.

GB virus C coinfection in advanced HIV type-1 disease is associated with low CCR5 and CXCR4 surface expression on CD4(+) T-cells

Genetic polymorphisms associated with fatty liver disease and fibrosis in HIV positive patients receiving combined antiretroviral therapy (cART).

HIV mono-infection is associated with an impaired anti-hepatitis C virus activity of natural killer cells

HIV protease inhibitors in combination with boceprevir: are drug-drug interactions the same for all patients?

HPV-associated anal lesions in HIV+ patients: long-term results regarding quality of life

Hepatitis C reinfection with protease inhibitor-resistant hepatitis C virus in an HIV-coinfected MSM

Hepatitis E Virus Seroprevalence Rate in HIV-Infected Patients in Germany: A Comparison of Two Commercial Assays

Hyper-IgD and periodic fever syndrome (HIDS) due to compound heterozygosity for G336S and V377I in a 44-year-old patient with a 27-year history of fever

Impact of low-level viremia on clinical and virological outcomes in treated HIV-1-infected patients

In vitro activity of mecillinam and nitroxoline against Neisseria gonorrhoeae - re-purposing old antibiotics in the multi-drug resistance era

Injection Drug Use and Hepatitis C as Risk Factors for Mortality in HIV-Infected Individuals: The Antiretroviral Therapy Cohort Collaboration

Limited Weight Impact After Switching From Boosted Protease Inhibitors to Dolutegravir in Persons With Human Immunodeficiency Virus With High Cardiovascular Risk: A Post Hoc Analysis of the 96-Week NEAT-022 Randomized Trial

Liver Fibrosis in HIV Patients Receiving a Modern cART: Which Factors Play a Role?

Liver fibrosis progression after acute hepatitis C virus infection in HIV-positive individuals

Moderate endurance training (marathon-training) - effects on immunologic and metabolic parameters in HIV-infected patients: the 42 KM cologne project.

Nevirapine pharmacokinetics in HIV-infected and HIV/HCV-coinfected individuals

Obstacles to hbv functional cure: Late presentation in HIV and its impact on HBV seroconversion in HIV/HBV coinfection

Return-to-health effect of modern combined antiretroviral therapy potentially predisposes HIV patients to hepatic steatosis.

Risk of selecting K65R in antiretroviral-naive HIV-infected individuals with chronic hepatitis B treated with adefovir

Role of GB virus C in modulating HIV disease

Survival and HLA-B*57 in HIV/HCV Co-Infected Patients on Highly Active Antiretroviral Therapy (HAART).

Switching from boosted PIs to dolutegravir decreases soluble CD14 and adiponectin in high cardiovascular risk people living with HIV

Switching tenofovir disoproxil fumarate to tenofovir alafenamide in a real life setting: what are the implications?

The German National Registry of Primary Immunodeficiencies (2012-2017)

The treatment of patients with HIV

Treatment modification after starting cART in people living with HIV: retrospective analysis of the German ClinSurv HIV Cohort 2005-2017

[Treatment of HIV in Pregnancy - Progress Over One Decade]

[Treatment of HPV-associated Anal Lesions in HIV-positive Patients - Comparison of Surgical Treatment and Topical Therapy with Imiquimod]

microRNA-200a: A stage-dependent biomarker and predictor of steatosis and liver cell injury in human immunodeficiency virus patients.